ZA888127B - Targeted forms of methyltrithio antitumor agents - Google Patents

Targeted forms of methyltrithio antitumor agents

Info

Publication number
ZA888127B
ZA888127B ZA888127A ZA888127A ZA888127B ZA 888127 B ZA888127 B ZA 888127B ZA 888127 A ZA888127 A ZA 888127A ZA 888127 A ZA888127 A ZA 888127A ZA 888127 B ZA888127 B ZA 888127B
Authority
ZA
South Africa
Prior art keywords
antitumor agents
targeted forms
methyltrithio antitumor
methyltrithio
targeted
Prior art date
Application number
ZA888127A
Other languages
English (en)
Inventor
William James Mcgahren
James Mcgahren William
Martin Leon Sassiver
Leon Sassiver Martin
George A Ellestad
A Ellestad George
Philip R Hamann
R Hamann Philip
Lois M Hinman
M Hinman Lois
Janis Upeslacis
Upeslacis Janis
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of ZA888127B publication Critical patent/ZA888127B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6807—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
    • A61K47/6809—Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
ZA888127A 1987-10-30 1988-10-28 Targeted forms of methyltrithio antitumor agents ZA888127B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11494087A 1987-10-30 1987-10-30

Publications (1)

Publication Number Publication Date
ZA888127B true ZA888127B (en) 1989-07-26

Family

ID=22358378

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA888127A ZA888127B (en) 1987-10-30 1988-10-28 Targeted forms of methyltrithio antitumor agents
ZA888123A ZA888123B (en) 1987-10-30 1988-10-28 Disulfur analogs of ll-e33288 antitumor agents

Family Applications After (1)

Application Number Title Priority Date Filing Date
ZA888123A ZA888123B (en) 1987-10-30 1988-10-28 Disulfur analogs of ll-e33288 antitumor agents

Country Status (19)

Country Link
EP (2) EP0313873B1 (xx)
JP (2) JP2820256B2 (xx)
KR (2) KR970011385B1 (xx)
AR (1) AR246083A1 (xx)
AT (2) ATE104309T1 (xx)
AU (2) AU612714B2 (xx)
BR (1) BR1100939A (xx)
CA (1) CA1321582C (xx)
DE (2) DE3889063T2 (xx)
DK (2) DK602488A (xx)
ES (2) ES2059464T3 (xx)
FI (2) FI95204C (xx)
HK (2) HK131997A (xx)
IE (2) IE65053B1 (xx)
IL (2) IL87946A (xx)
NO (2) NO176480C (xx)
NZ (2) NZ226726A (xx)
PT (2) PT88881B (xx)
ZA (2) ZA888127B (xx)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000032773A1 (en) 1998-11-27 2000-06-08 Darwin Discovery Ltd. Compositions and methods for increasing bone mineralization
WO2005003158A2 (en) 2003-06-16 2005-01-13 Celltech R & D, Inc. Compositions and methods for increasing bone mineralization
WO2005014650A2 (en) 2003-06-16 2005-02-17 Celltech R & D, Inc. Antibodies specific for sclerostin and methods for increasing bone mineralization

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079233A (en) * 1987-01-30 1992-01-07 American Cyanamid Company N-acyl derivatives of the LL-E33288 antitumor antibiotics, composition and methods for using the same
US5606040A (en) * 1987-10-30 1997-02-25 American Cyanamid Company Antitumor and antibacterial substituted disulfide derivatives prepared from compounds possessing a methyl-trithio group
IL93733A (en) * 1989-04-14 1996-01-19 American Cyanamid Co History of Dissolved Drug Sulphides Antibacterial and Antibacterial, Prepared from Compounds Containing Methyl-Thriteo Groups and Their Target Form
GB9007384D0 (en) * 1990-04-02 1990-05-30 Duncan Ruth Coupling between polymers and other organic molecular entities utilising thiol-specific reactive groups
US5712374A (en) * 1995-06-07 1998-01-27 American Cyanamid Company Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates
US5714586A (en) * 1995-06-07 1998-02-03 American Cyanamid Company Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates
NZ511705A (en) * 2001-05-14 2004-03-26 Horticulture & Food Res Inst Methods and rapid immunoassay device for detecting progesterone and other steroids
WO2008028050A2 (en) * 2006-08-30 2008-03-06 Wisconsin Alumni Research Foundation Reversible natural product glycosyltransferase-catalyzed reactions, compounds and related methods
KR100979928B1 (ko) * 2008-07-16 2010-09-03 한주학 수직축형 부력풍차
JP6494240B2 (ja) * 2013-11-04 2019-04-03 ファイザー・インク カリケアマイシン誘導体を合成するための中間体および方法
US20190345186A1 (en) * 2017-01-24 2019-11-14 Pfizer Inc. Calicheamicin deratives and antibody drug conjugates thereof
KR20210118945A (ko) 2019-02-15 2021-10-01 유니버시티 오브 써던 캘리포니아 Lym-1 및 lym-2 항체 조성물 및 개선된 car 구성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2430943A1 (fr) * 1978-07-13 1980-02-08 Toyo Jozo Kk Nouveaux derives disulfures
EP0040506B1 (en) * 1980-05-21 1986-08-20 Teijin Limited Reactive polymer and process for the preparation thereof
US4530835A (en) * 1983-07-08 1985-07-23 Warner-Lambert Company CL-1577 Antibiotic compounds and their production
CA1314245C (en) * 1984-05-23 1993-03-09 Franz Jansen Process for the preparation of conjugates in which a monovalent carboxylic ionophore is associated by means of a covalent bond with a macromolecule, which are useful as immunotoxin potentiators
ATE180513T1 (de) * 1984-11-16 1999-06-15 American Cyanamid Co Antitumorale antibiotika (komplex ll-e-33288)
EP0330874A3 (en) * 1988-02-29 1989-10-18 American Cyanamid Company Antibacterial and antitumor agents LL-E33288 epsilon-I and LL-E33288-epsilonBr, with processes and intermediates for producing said agents
EP0342341A3 (en) * 1988-05-17 1991-07-24 American Cyanamid Company Process for producing antitumor antibiotic ll-e33288gamma2

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000032773A1 (en) 1998-11-27 2000-06-08 Darwin Discovery Ltd. Compositions and methods for increasing bone mineralization
EP2261335A1 (en) 1998-11-27 2010-12-15 UCB Pharma S.A. Compositions and methods for increasing bone mineralisation
WO2005003158A2 (en) 2003-06-16 2005-01-13 Celltech R & D, Inc. Compositions and methods for increasing bone mineralization
WO2005014650A2 (en) 2003-06-16 2005-02-17 Celltech R & D, Inc. Antibodies specific for sclerostin and methods for increasing bone mineralization
EP2338906A1 (en) 2003-06-16 2011-06-29 UCB Manufacturing, Inc. Compostion and methods for increasing bone mineralization
EP2341071A1 (en) 2003-06-16 2011-07-06 UCB Manufacturing, Inc. Compostion and methods for increasing bone mineralization

Also Published As

Publication number Publication date
DK602588D0 (da) 1988-10-28
NO884834L (no) 1989-05-02
ATE112172T1 (de) 1994-10-15
JP2820256B2 (ja) 1998-11-05
IL87946A (en) 1995-06-29
AU618763B2 (en) 1992-01-09
FI884984A0 (fi) 1988-10-28
FI95204C (fi) 1996-01-10
JPH01193282A (ja) 1989-08-03
NO173506B (no) 1993-09-13
DK174739B1 (da) 2003-10-13
KR890006245A (ko) 1989-06-12
ZA888123B (en) 1989-07-26
AU2448988A (en) 1989-05-04
FI95204B (fi) 1995-09-29
JP2720933B2 (ja) 1998-03-04
IE883262L (en) 1989-04-30
KR970011385B1 (ko) 1997-07-10
NO173506C (no) 1993-12-22
PT88881B (pt) 1993-01-29
ES2061586T3 (es) 1994-12-16
DK602488D0 (da) 1988-10-28
AU2449488A (en) 1989-05-04
ES2059464T3 (es) 1994-11-16
DK602488A (da) 1989-05-01
NO884833L (no) 1989-05-02
NZ226726A (en) 1991-08-27
EP0313874A2 (en) 1989-05-03
ATE104309T1 (de) 1994-04-15
DE3889063T2 (de) 1994-12-01
EP0313874A3 (en) 1990-05-09
DK602588A (da) 1989-05-01
NO884833D0 (no) 1988-10-28
AU612714B2 (en) 1991-07-18
DE3889063D1 (de) 1994-05-19
EP0313873A1 (en) 1989-05-03
FI884983A0 (fi) 1988-10-28
IL87947A0 (en) 1989-03-31
KR890006244A (ko) 1989-06-12
HK131897A (en) 1997-10-03
FI884983A (fi) 1989-05-01
HK131997A (en) 1997-10-03
IL87947A (en) 1995-05-26
EP0313873B1 (en) 1994-09-28
IL87946A0 (en) 1989-03-31
NO884834D0 (no) 1988-10-28
IE65053B1 (en) 1995-10-04
KR0133130B1 (ko) 1998-04-17
NZ226727A (en) 1991-12-23
PT88882B (pt) 1993-01-29
IE883261L (en) 1989-04-30
FI91262C (fi) 1994-06-10
IE65989B1 (en) 1995-11-29
JPH0296599A (ja) 1990-04-09
EP0313874B1 (en) 1994-04-13
DE3851682T2 (de) 1995-05-04
BR1100939A (pt) 1999-08-31
CA1321582C (en) 1993-08-24
NO176480C (no) 1995-04-12
NO176480B (no) 1995-01-02
FI91262B (fi) 1994-02-28
FI884984A (fi) 1989-05-01
DE3851682D1 (de) 1994-11-03
AR246083A1 (es) 1994-03-30

Similar Documents

Publication Publication Date Title
GB8801560D0 (en) Antioxygen agents
GB8727737D0 (en) Antitumour agents
IL87947A0 (en) Targeted forms of methyltrithio antitumor agents
EP0310386A3 (en) Therapeutic agents
GB8821380D0 (en) Antiviral agents
GB8704532D0 (en) Treatment of froth
GB8716975D0 (en) Therapeutic agents
GB8701392D0 (en) Therapeutic agents
GB8727792D0 (en) Therapeutic agents
YU146288A (en) Derivatives of benzimidazole-2-il-pyridinium
GB2217729B (en) Obtenation of scualane
JPS6429333A (en) Manufacture of alpha-fluoroketones
ZA902840B (en) Targeted forms of methyltrithio antitumor agents
PH27270A (en) Targeted forms of methyltrithio antitumor agents
IE901332L (en) Targeted forms of methylthio antitumor agents
IE872159L (en) Antitumor agent
GB8721343D0 (en) Therapeutic agents
GB8721342D0 (en) Therapeutic agents
JPS6416754A (en) Manufacture of n-alkoxycarbonylmethyl-n-formyl- amines and -anilines
HK1021820A1 (en) Derivatives of n-phenylpyrazoles
GB8715722D0 (en) Therapeutic agents
IE870521L (en) Therapeutic agents
GB8709842D0 (en) Therapeutic agents
GB8727990D0 (en) Therapeutic agents
GB8729926D0 (en) Therapeutic agents